332 related articles for article (PubMed ID: 24793669)
1. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
Zografos TA; Katritsis GD; Tsiafoutis I; Bourboulis N; Katsivas A; Katritsis DG
Am J Cardiol; 2014 Jun; 113(12):2013-7. PubMed ID: 24793669
[TBL] [Abstract][Full Text] [Related]
2. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial.
Hoole SP; Heck PM; Sharples L; Khan SN; Duehmke R; Densem CG; Clarke SC; Shapiro LM; Schofield PM; O'Sullivan M; Dutka DP
Circulation; 2009 Feb; 119(6):820-7. PubMed ID: 19188504
[TBL] [Abstract][Full Text] [Related]
4. Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention.
Ahmed RM; Mohamed el-HA; Ashraf M; Maithili S; Nabil F; Rami R; Mohamed TI
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E647-53. PubMed ID: 23404916
[TBL] [Abstract][Full Text] [Related]
5. Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation.
Luo SJ; Zhou YJ; Shi DM; Ge HL; Wang JL; Liu RF
Can J Cardiol; 2013 Sep; 29(9):1084-9. PubMed ID: 23414904
[TBL] [Abstract][Full Text] [Related]
6. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
[TBL] [Abstract][Full Text] [Related]
8. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis.
Hong YJ; Mintz GS; Kim SW; Lee SY; Okabe T; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ
JACC Cardiovasc Imaging; 2009 Apr; 2(4):458-68. PubMed ID: 19580729
[TBL] [Abstract][Full Text] [Related]
9. Effects of remote ischemic preconditioning on myocardial injury and endothelial function and prognosis after percutaneous coronary intervention in patients with acute coronary syndrome.
Zhou FZ; Song W; Yin LH; Song ZF; Yang S; Yang FB; Liu JF; Song YG; Zhang HY; Zhang ZM
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4642-4648. PubMed ID: 29131250
[TBL] [Abstract][Full Text] [Related]
10. Remote ischemic postconditioning during percutaneous coronary interventions: remote ischemic postconditioning-percutaneous coronary intervention randomized trial.
Lavi S; D'Alfonso S; Diamantouros P; Camuglia A; Garg P; Teefy P; Jablonsky G; Sridhar K; Lavi R
Circ Cardiovasc Interv; 2014 Apr; 7(2):225-32. PubMed ID: 24692535
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of electroacupuncture pretreatment for myocardial injury in patients undergoing percutaneous coronary intervention: A randomized clinical trial with a 2-year follow-up.
Wang Q; Liang D; Wang F; Li W; Han Y; Zhang W; Xie Y; Xin W; Zhou B; Sun D; Cao F; Xiong L
Int J Cardiol; 2015 Sep; 194():28-35. PubMed ID: 26011261
[TBL] [Abstract][Full Text] [Related]
12. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
13. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Millán-Vázquez G; Guerrero-Molina A; Ortiz-García C; Enguix-Armada A; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E; Jiménez-Navarro MF
Heart; 2013 Oct; 99(19):1431-7. PubMed ID: 23850844
[TBL] [Abstract][Full Text] [Related]
14. Multimodality Intravascular Imaging to Predict Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention.
Kini AS; Motoyama S; Vengrenyuk Y; Feig JE; Pena J; Baber U; Bhat AM; Moreno P; Kovacic JC; Narula J; Sharma SK
JACC Cardiovasc Interv; 2015 Jun; 8(7):937-45. PubMed ID: 26088511
[TBL] [Abstract][Full Text] [Related]
15. Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary intervention.
Hoole SP; Heck PM; White PA; Khan SN; O'Sullivan M; Clarke SC; Dutka DP
Angiology; 2009; 60(4):403-11. PubMed ID: 19106155
[TBL] [Abstract][Full Text] [Related]
16. Remote ischemic postconditioning: does it protect against ischemic damage in percutaneous coronary revascularization? justification and design of a randomized placebo-controlled clinical trial.
Jiménez-Navarro MF; Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Caballero-Borrego J; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E
Cardiology; 2011; 119(3):164-9. PubMed ID: 21952349
[TBL] [Abstract][Full Text] [Related]
17. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action.
Rentoukas I; Giannopoulos G; Kaoukis A; Kossyvakis C; Raisakis K; Driva M; Panagopoulou V; Tsarouchas K; Vavetsi S; Pyrgakis V; Deftereos S
JACC Cardiovasc Interv; 2010 Jan; 3(1):49-55. PubMed ID: 20129568
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome following remote ischemic postconditioning during percutaneous coronary interventions-the RIP-PCI trial long-term follow-up.
Lavi S; Abu-Romeh N; Wall S; Alemayehu M; Lavi R
Clin Cardiol; 2017 May; 40(5):268-274. PubMed ID: 28075499
[TBL] [Abstract][Full Text] [Related]
20. Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials.
D'Ascenzo F; Moretti C; Omedè P; Cerrato E; Cavallero E; Er F; Presutti DG; Colombo F; Crimi G; Conrotto F; Dinicolantonio JJ; Chen S; Prasad A; Biondi Zoccai G; Gaita F
EuroIntervention; 2014; 9(12):1463-71. PubMed ID: 24755386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
